Jin Medical International (ZJYL) Accounts Payables (2022 - 2025)

Jin Medical International (ZJYL) has reported Accounts Payables for 4 consecutive years, with $3.3 million the latest figure, recorded in Q3 2025.

• Quarterly Accounts Payables rose 8.11% year-over-year to $3.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $3.3 million (up 8.11% YoY) and the FY2025 annual result came in at $3.3 million, up 8.11% from the prior year.
• Accounts Payables rose to $3.3 million in Q3 2025 per ZJYL's latest filing, from $3.1 million in the prior quarter.
• Over the last five years, Accounts Payables for ZJYL reached as high as $4.6 million in Q1 2023 and fell as low as $3.0 million in Q3 2024.
• A 4-year average of $3.5 million and a median of $3.3 million in 2025 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2024 — Accounts Payables plunged 31.81% — and 2025, when it increased 8.11%.
• Year by year, Accounts Payables stood at $4.1 million in 2022, then retreated by 17.56% to $3.4 million in 2023, then dropped by 11.17% to $3.0 million in 2024, then climbed by 8.11% to $3.3 million in 2025.
• According to Business Quant data, Accounts Payables over the past three periods registered $3.3 million, $3.1 million, and $3.0 million for Q3 2025, Q1 2025, and Q3 2024 respectively.